Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|August 31, 2021
- Ophthalmology Times: August 2021
- Volume 46
- Issue 12
Eye contraptions
Author(s)Jon Carter
Check out the latest cartoon!
Advertisement
Articles in this issue
about 5 years ago
Early outer retinal findings on en face and cross-sectional OCTabout 5 years ago
Presbyopia-correcting IOL improves vision for patientsabout 5 years ago
AAV gene therapy targets autoimmune uveitisabout 5 years ago
Ophthalmology Foundation focuses on mission of visionabout 5 years ago
Optimizing the management of DEDabout 5 years ago
Detailing consequences of Demodex blepharitisabout 5 years ago
Editorial: Yes, ophthalmologists are real doctorsabout 5 years ago
Four tips for growing a proactive practiceabout 5 years ago
FDA approves cyclosporine A eye drop for vernal keratoconjunctivitisAdvertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA approves subcutaneous Enspryng for TED
2
OT Roundup: Optogenetics Nobel Prize, BRUNELLO, DRAGON, eye transplant
3
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
4
AAO 2026: Vamikibart shows sustained gains in uveitic macular edema as FDA accepts BLA
5